5MYV | Transferase | date | Jan 29, 2017 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Srpk2 In Complex With Compound 1 | ||||||||||||||
authors | A.Chaikuad, A.C.W.Pike, P.Savitsky, F.Von Delft, C.Bountra, A.M.E C.H.Arrowsmith, S.Knapp, Structural Genomics Consortium (Sgc) | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Srsf Protein Kinase 2,Srsf Protein Kinase 2 Chain: A, B, C, D Fragment: Unp Residues 51-256,Unp Residues 508-688 Synonym: Sfrs Protein Kinase 2,Serinearginine-Rich Protein Kinase 2,Sr-Protein-Specific Kinase 2,Sfrs Protein Kinase 2 Serinearginine-Rich Protein-Specific Kinase 2,Sr-Protein-S Kinase 2; Ec: 2.7.11.1,2.7.11.1 Engineered: Yes |
Organism_scientific: Homo Sapiens Organism_common: Human Organism_taxid: 9606 Gene: Srpk2 Expression_system: Escherichia Coli Bl21(De3) Expression_system_taxid: 469008 Expression_system_variant: R3-Prare2 Expression_system_vector_type: Plasmid Expression_system_plasmid: Pnic28-Bsa4 | ||||||||||||||
symmetry | Space Group: C 2 2 21 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.90 Å | ||||||||||||
ligand | DMS, SO4, W4A | enzyme | Transferase E.C.2.7.11.1 BRENDA | ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease., Batson J, Toop HD, Redondo C, Babaei-Jadidi R, Chaikuad A, Wearmouth SF, Gibbons B, Allen C, Tallant C, Zhang J, Du C, Hancox JC, Hawtrey T, Da Rocha J, Griffith R, Knapp S, Bates DO, Morris JC, ACS Chem Biol. 2017 Mar 17;12(3):825-832. doi: 10.1021/acschembio.6b01048. Epub, 2017 Feb 6. PMID:28135068 |
Data retrieval |
View 5MYV in 3D |
Visual 3D analysis of 5MYV |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5MYV |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |